JP2002501004A5 - - Google Patents

Download PDF

Info

Publication number
JP2002501004A5
JP2002501004A5 JP2000510774A JP2000510774A JP2002501004A5 JP 2002501004 A5 JP2002501004 A5 JP 2002501004A5 JP 2000510774 A JP2000510774 A JP 2000510774A JP 2000510774 A JP2000510774 A JP 2000510774A JP 2002501004 A5 JP2002501004 A5 JP 2002501004A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000510774A
Other versions
JP4334761B2 (ja
JP2002501004A (ja
Filing date
Publication date
Priority claimed from AUPO9001A external-priority patent/AUPO900197A0/en
Priority claimed from AUPP0398A external-priority patent/AUPP039897A0/en
Application filed filed Critical
Priority claimed from PCT/AU1998/000724 external-priority patent/WO1999012969A1/en
Publication of JP2002501004A publication Critical patent/JP2002501004A/ja
Publication of JP2002501004A5 publication Critical patent/JP2002501004A5/ja
Application granted granted Critical
Publication of JP4334761B2 publication Critical patent/JP4334761B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000510774A 1997-09-08 1998-09-04 肥満の処置 Expired - Fee Related JP4334761B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPO9001A AUPO900197A0 (en) 1997-09-08 1997-09-08 Treatment of obesity
AUPP0398A AUPP039897A0 (en) 1997-11-13 1997-11-13 Treatment of obesity
AU9001 1997-11-13
AU0398 1997-11-13
PCT/AU1998/000724 WO1999012969A1 (en) 1997-09-08 1998-09-04 Treatment of obesity

Publications (3)

Publication Number Publication Date
JP2002501004A JP2002501004A (ja) 2002-01-15
JP2002501004A5 true JP2002501004A5 (ja) 2005-12-22
JP4334761B2 JP4334761B2 (ja) 2009-09-30

Family

ID=25645599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000510774A Expired - Fee Related JP4334761B2 (ja) 1997-09-08 1998-09-04 肥満の処置

Country Status (12)

Country Link
US (2) US6737407B1 (ja)
EP (1) EP1012189B1 (ja)
JP (1) JP4334761B2 (ja)
CN (1) CN1195776C (ja)
AT (1) ATE377026T1 (ja)
BR (1) BR9811755A (ja)
CA (1) CA2303395C (ja)
DE (1) DE69838647T2 (ja)
ES (1) ES2296342T3 (ja)
NZ (1) NZ502993A (ja)
RU (1) RU2223970C2 (ja)
WO (1) WO1999012969A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ387599A0 (en) 1999-11-05 1999-12-02 Metabolic Pharmaceuticals Limited Product and method for control of obesity
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
AU2003263552A1 (en) * 2002-09-09 2004-03-29 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
GB0315182D0 (en) * 2003-06-28 2003-08-06 Asterion Ltd Cytokine variant polypeptides
WO2005007859A2 (en) * 2003-07-11 2005-01-27 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF ACETYL-COA CARBOXYLASE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP1755637B8 (en) * 2004-05-04 2012-10-03 Metabolic Pharmaceuticals Ltd. Methods for preventing or treating bone disorders
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
ES2258923B1 (es) * 2005-02-23 2007-11-01 Universitat De Les Illes Balears Uso de la leptina para la prevencion del exceso de peso corporal y composicion que contiene leptina.
EP1919506A1 (en) * 2005-08-02 2008-05-14 Metabolic Pharmaceuticals Ltd. Peptide conjugate for oral delivery of hydrophilic peptide analgesics
WO2007068039A1 (en) * 2005-12-12 2007-06-21 Metabolic Pharmaceuticals Limited Treatment of weight gain in estrogen deficient mammals
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法
WO2008098280A1 (en) * 2007-02-16 2008-08-21 Polychip Pharmaceuticals Pty Ltd Methods for the synthesis of dicarba bridges in growth hormone peptides
WO2010033215A2 (en) * 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of aod-like peptides
WO2010033240A2 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
US10111933B2 (en) * 2011-12-09 2018-10-30 Metabolic Pharmaceuticals Pty Ltd Use of growth hormone fragments
CN102827290A (zh) * 2012-09-07 2012-12-19 浙江大学 人血清白蛋白与人生长激素脂肪分解结构域的融合蛋白
GB2507341A (en) * 2012-10-29 2014-04-30 Peter Kenny Fat loss composition comprising a prostaglandin F2 alpha analogue and a fragment of amino acids 176-191 of human growth hormone
EP3740228A4 (en) * 2018-01-15 2021-12-15 Lateral Ip Pty Ltd PEPTIDES AND THEIR USES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG49718A3 (en) 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
US4863901A (en) 1986-01-09 1989-09-05 Brigham & Women's Hospital Use of growth hormone for nitrogen retention under hypocaloric conditions
US5534617A (en) * 1988-10-28 1996-07-09 Genentech, Inc. Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
US5126324A (en) 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
AU693478B2 (en) 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity

Similar Documents

Publication Publication Date Title
BE2014C048I2 (ja)
IN188249B (ja)
BE2009C051I2 (ja)
BRPI9917862A2 (ja)
BRPI9914151B8 (ja)
FR11C0028I1 (ja)
JP2002501004A5 (ja)
JP2003526954A5 (ja)
JP2566993C (ja)
JP2562992C (ja)
JP2520266Z (ja)
IN190800B (ja)
JP2550013C (ja)
IN191342B (ja)
JP2548129C (ja)
JP2542521C (ja)
JP2542414C (ja)
JP2538106C (ja)
JP2500162Z (ja)
CN3073190S (ja)
CN3074906S (ja)
CN3072756S (ja)
CN3071793S (ja)
CN3072873S (ja)
BY6371C1 (ja)